Subscribe
shutterstock_1066944104_siradawichitaphornkun
Sirada Wichitaphornkun / Shutterstock.com
21 August 2019AmericasSarah Morgan

Bayer to sell off animal health business for $7.6bn

Bayer has agreed to sell its animal health business to US-based Elanco Animal Health for $7.6 billion, as part of its strategic plan to focus on its core life sciences businesses.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Bayer buys BlueRock to build cell therapy expertise
9 August 2019   Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion.
Americas
BASF and Royal DSM embroiled in animal feed patent suits
16 April 2020   Bulgaria-based Huvepharma has accused chemicals company BASF and Dutch life sciences Koninklijke DSM, known as Royal DSM, of infringing its feed additive.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Bayer buys BlueRock to build cell therapy expertise
9 August 2019   Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion.
Americas
BASF and Royal DSM embroiled in animal feed patent suits
16 April 2020   Bulgaria-based Huvepharma has accused chemicals company BASF and Dutch life sciences Koninklijke DSM, known as Royal DSM, of infringing its feed additive.

More on this story

Americas
Bayer buys BlueRock to build cell therapy expertise
9 August 2019   Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion.
Americas
BASF and Royal DSM embroiled in animal feed patent suits
16 April 2020   Bulgaria-based Huvepharma has accused chemicals company BASF and Dutch life sciences Koninklijke DSM, known as Royal DSM, of infringing its feed additive.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility